Cannabis Law Report

FEBRUARY 13, 2022

The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices.

Programs 52

Programs Research and Development Seed-To-Sale Compliance 52

MMJ Recs

MARCH 16, 2024

Recent trends indicate a growing interest in alternative forms of consumption, such as edibles, topicals, and concentrates, in addition to traditional flower products. Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. As an example, look at the bubble of CBD in the last year to see consumers swooning over science that is yet to be regulated and false or misleading packaging that profligates on shelves across the US.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

SpeedWeed

MARCH 19, 2021

Because hemp-derived CBD is only legal for sale as a topical in the state, it’d bring about a lifeline for Massachusetts’ struggling hemp industry. SEE MORE: 2020 Hemp Cultivation Data By State. We’re allowed to sell our products everywhere in the state except dispensaries,” says Beohner, who only sells topical products.

Hemp 52

Hemp Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. A prominent example is the price of cannabis products.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Five of them used an age verification form , which is in compliance with the FDA age requirements and state laws, where the customer has to upload a photo of a government ID, and the other required a signature on delivery of the package.

THC 96

THC CBD Legalization Vaping 96

Marijuana Packaging

OCTOBER 25, 2018

California’s New Packaging Rules and Regulations. The changes place the brunt of the responsibility for child resistance on dispensaries, giving manufacturers and producers until 2020 to get their packaging up to state compliance standards. Edibles will need child-resistant packaging designed to run the duration of their expected use.

Cannabinoids 40

Cannabinoids Packaging Recreational Cannabis 40

Cannabis Law Report

DECEMBER 6, 2021

Job Application Package Checklist. The Department’s mission is to develop and implement progressive cannabis policies, while regulating commercial cannabis activity in a way that best protects public health, safety, the environment, and local communities throughout the State of California. Address for Drop-Off Application Packages.

Packaging 52

Packaging Environment Conditions Education 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. Excise taxes.

Vaping 105

Vaping Research and Development Data Business 105

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). With our extensive preclinical development package in hand, we are positioned to efficiently pursue additional indications for INM-755. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . triggering new innovations and improved data quality through better user experiences.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

NOVEMBER 10, 2021

as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. Once completed, it is our intention to immediately submit our IND package to the FDA so that we may begin human trials,” commented Virpax’s Chairman & CEO Anthony P. About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Otherside Farms

DECEMBER 10, 2019

While there are no comprehensive scientific data on victimization CBD to treat dogs, there’s anecdotal proof from doghouse owners suggesting it will treat pain, particularly neuropathic pain, moreover, as serving to manage seizures. The safety and risks of CBD for dogs haven’t but been researched. Risks of CBD Oil for Dogs.

Oil 18

Oil CBD Pets Blood Pressure 18

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). With our extensive preclinical development package in hand, we are positioned to efficiently pursue additional indications for INM-755. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. I don’t know if we’ll have topicals initially, or later on. It has the – you assume safety, at least to a certain level.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Meadow

JULY 13, 2018

Below are the questions and topics covered in the State of the Industry panel with timestamps: What are you most excited about right now? (0:30) I think bleach kills more people than this and we don’t put any safety labels on that. we want everyone who did not have the opportunity to attend Meadowlands to have access to this content.

Supply Chain 40

Supply Chain Compliance Compliance Cannabis 40

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

MAY 14, 2022

Access to banking is a well-known issue for the cannabis industry and the repeated efforts to obtain the bill’s congressional passage over the past few years remains a hot topic for industry insiders and participants. MI – Michigan cannabis regulators axed a plan to allow hemp to be synthetically converted to THC.

Banking 52

Banking Recreational Research and Development Cannabis 52